|
Volumn 25, Issue 3, 1998, Pages 340-348
|
Chemotherapy of advanced ovarian cancer
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
ETOPOSIDE;
GEMCITABINE;
NAVELBINE;
PACLITAXEL;
TOPOTECAN;
ADVANCED CANCER;
BLOOD TOXICITY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOTOXICITY;
DOSE RESPONSE;
FEMALE;
GASTROINTESTINAL TOXICITY;
HUMAN;
MYALGIA;
NEUROTOXICITY;
OVARY CARCINOMA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
CISPLATIN;
CLINICAL TRIALS;
FEMALE;
HUMANS;
OVARIAN NEOPLASMS;
PACLITAXEL;
|
EID: 0031745255
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (184)
|
References (49)
|